Latest Private Placement News

CAR Group Ltd reported a robust half-year performance for the period ending December 31, 2024, with revenue up 9% and profit growth across all key markets. The company declared a 38.5 cents per share interim dividend, underscoring its strong financial position and confidence in future growth.

Critical Metals Corp. has secured US$22.5 million through a private placement to advance its Tanbreez Rare Earth Project in Greenland and Wolfsberg Lithium Project in Austria, reinforcing its position in the critical metals supply chain for Europe.

Hotel Property Investments (HPI) reported a solid $16.7 million statutory profit for H1 FY25, alongside a 3.2% rise in distributions and a successful debt refinancing that extends maturity and reduces costs.

Predictive Discovery Limited has raised A$69.2 million through a strategic placement with the Lundin Family and Zijin Mining, bolstering its financial position to advance the Bankan Gold Project in Guinea.

DomaCom Limited reports a transformative quarter with executive changes, new funding facilities, and strategic initiatives including the launch of its Homeowner Equity Fund and exclusive licensing of the Bricklet Homeowner Platform.

Argent BioPharma reports strategic cost-cutting moves including facility closures and delisting from the LSE, while securing German distribution approval and raising significant capital to support its drug pipeline.

Challenger Gold Limited posted a $2.1 million net cash outflow for the December quarter amid heavy exploration spending but secured $6.6 million in fresh funding shortly after quarter-end.

DigitalX Limited reported a 15% revenue increase in Q4 2024, driven by staking activities and performance fees, alongside a $10.3 million private placement and strategic Solana investment. The DigitalX Bitcoin ETF surpassed $50 million in funds under management, delivering a 67.4% quarterly return.

Mesoblast has secured FDA approval for Ryoncil®, the first mesenchymal stromal cell therapy for steroid-refractory acute graft versus host disease in children, while raising A$260 million to accelerate clinical trials and commercial rollout.

AuMEGA Metals has unveiled plans for a major 2025 drilling program focused on its Bunker Hill project, backed by a successful C$16 million private placement. Recent exploration results highlight promising gold and copper targets across its Newfoundland portfolio.

Radiopharm Theranostics has secured key ethics approvals to expand its clinical trial portfolio, completed significant preclinical milestones, and raised A$8 million through a strategic placement, while maintaining its cash runway to mid-2026.

Chilwa Minerals has completed a major drilling program at its Mposa deposit and launched a dual commodity strategy targeting both heavy mineral sands and rare earth elements, supported by a fresh $6 million capital raise.